BSX

Boston Scientific
D

BSX

Arincen84/100B
44.305
USD
0.16
(0.36%)
Market Open
Last updated: · Delayed 15 min
Fair value62.64Plus-29%47Price 44.3178
Q4 FY2026 · Earnings report
EPS estimate 0.78Revenue estimate 5.18B
OverviewFinancialsNewsForecastEarningsCompany

Boston Scientific revenue 1991–2026

Boston Scientific's revenue in Q3 FY2026, the three months to 30 September 2026, was 5.14B USD, up 1.4% on the same quarter a year before. Boston Scientific's revenue over the last twelve months was 21.07B USD, up 8.9% on the twelve months before. In fiscal year 2025 it was 20.07B USD, up 19.9% on the year before.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 202621.07B+8.88%14.83B3.49B
FY202531 Dec 202520.07B+19.87%13.85B2.89B
FY202431 Dec 202416.75B+17.61%10.27B1.85B
FY202331 Dec 202314.24B+12.29%8.83B1.59B
FY202231 Dec 202212.68B+6.68%7.71B698.00M
FY202131 Dec 202111.89B+19.92%7.46B1.04B
FY202031 Dec 20209.91B-7.66%5.58B-82.00M
FY201931 Dec 201910.74B+9.28%6.88B4.70B
FY201831 Dec 20189.82B+8.57%6.48B1.67B
FY201731 Dec 20179.05B+7.89%5.87B104.00M
FY201631 Dec 20168.39B+12.16%5.34B347.00M
FY201531 Dec 20157.48B+1.31%4.56B-239.00M
FY201431 Dec 20147.38B+3.32%4.59B-119.00M
FY201331 Dec 20137.14B-1.46%4.54B-121.00M
FY201231 Dec 20127.25B-4.89%4.56B-4.07B
FY201131 Dec 20117.62B-2.36%4.68B441.00M
FY201031 Dec 20107.81B-4.67%4.79B-1.07B
FY200931 Dec 20098.19B+1.71%5.18B-1.03B
FY200831 Dec 20088.05B-3.67%5.09B-2.04B
FY200731 Dec 20078.36B+6.85%5.40B-495.00M
FY200631 Dec 20067.82B+24.48%5.08B-3.58B
FY200531 Dec 20056.28B+11.72%4.75B628.00M
FY200431 Dec 20045.62B+61.80%4.28B1.06B
FY200331 Dec 20033.48B+19.08%2.52B472.00M
FY200231 Dec 20022.92B+9.20%2.05B373.00M
FY200131 Dec 20012.67B+0.34%1.75B-54.00M
FY200031 Dec 20002.66B-6.26%1.92B373.00M
FY199931 Dec 19992.84B+27.24%1.94B371.00M
FY199831 Dec 19982.23B+19.30%1.57B-264.40M
FY199731 Dec 19971.87B+28.06%1.41B139.30M
FY199631 Dec 19961.46B+32.07%1.12B167.10M
FY199531 Dec 19951.11B+146.60%830.00M8.00M
FY199431 Dec 1994448.90M+18.10%295.80M79.70M
FY199331 Dec 1993380.10M+20.59%246.20M69.70M
FY199231 Dec 1992315.20M+37.04%203.30M56.60M
FY199131 Dec 1991230.00M—151.60M41.80M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Boston Scientific revenue growth by segment

Q3 FY2026 against Q3 FY2025

Cardiovascular3.41B
+1.9%
MedSurg1.73B
+0.6%

Boston Scientific revenue by segment over time

Cardiovascular MedSurg Cardiac Rhythm Management
Fiscal yearCardiovascularMedSurgCardiac Rhythm Management
FY202513.27B +23.3%6.83B +13.9%—
FY202410.76B +22.0%5.99B +10.5%—
FY20238.82B +8.1%5.42B +7.2%—
FY20228.16B +68.0%5.06B +35.8%—
FY20214.86B +25.3%3.72B +21.5%3.29B
FY20203.88B -7.9%3.07B -7.3%—
FY20194.21B +11.4%3.31B +10.0%—
FY20183.78B +7.9%3.01B -11.0%—
FY20173.50B -3.2%3.38B +5.4%—
FY20163.62B +12.4%3.20B +20.0%—

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Boston Scientific's revenue

Source: Financial Modeling Prep